TCI Wealth Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

TCI Wealth Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-335	Closed	-$17K	–	2713
2022 Q3	$17K	Hold	335	–	–	﹤0.01%	746
2022 Q2	$8K	Hold	335	–	–	﹤0.01%	1201
2022 Q1	$8K	Hold	335	–	–	﹤0.01%	1284
2021 Q4	$12K	Hold	335	–	–	﹤0.01%	1066
2021 Q3	$6K	Hold	335	–	–	﹤0.01%	1537
2021 Q2	$4K	Buy	335 +281	+520%	+$6.92K	﹤0.01%	1674
2021 Q1	$3K	Buy	+54	New	+$3.25K	﹤0.01%	1629

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TCI Wealth Advisors's CCXI Position: Q4 2022 in Review

TCI Wealth Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 335 shares — an estimated $17K sold.

TCI Wealth Advisors first reported a position in CCXI in Q1 2021 and held it in 7 quarters. The position peaked at $17K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

TCI Wealth Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
TCI Wealth Advisors sold 335 ChemoCentryx, Inc. shares in Q4 2022, an estimated $17K.
TCI Wealth Advisors first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 7 quarters.
TCI Wealth Advisors's ChemoCentryx, Inc. position peaked at $17K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.